Astellas gains worldwide rights to develop XNW2701 being evaluated in solid tumors, including gastric, gastroesophageal and ...

HHS previously awarded $176 million for a mRNA-based vaccine against the H5N1 avian influenza. Moderna, Inc. received notice ...

Bora Pharmaceuticals Co. Ltd. has announced plans to add further sterile fill/finish capacity at its facility in Baltimore, ...

Bionique Testing Laboratories and Cellipont Bioservices have partnered to advance the adoption and validation of rapid ...

LyoWave has also received a $50,000 Phase I grant from the Indiana Economic Development Corp.’s Applied Research Institute.

In today’s high-stakes pharma environment, where supply chain risks, rising tariffs, and time-to-market pressures dominate, ...

GRIN Therapeutics Inc. and Angelini Pharma have partnered for the development and commercial rights outside of North America ...

Collaboration combines Nuclera’s eProtein Discovery System with Cytiva’s Biacore SPR system.

Hillstar Bio, a leading biotechnology company focused on developing immunology therapies for autoimmune diseases, appointed ...

Lifecore Biomedical Inc., a fully integrated CDMO, has appointed Mark DaFonseca as its Chief Commercial Officer.

The U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Novavax Inc.’s Nuvaxovid ...

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.